Kainic acid-induced seizures modulate Akt (SER473) phosphorylation in the hippocampus of dopamine D2 receptor knockout mice

Journal of Molecular Neuroscience

Volumn 49, Issue 1, 2013, Pages 202-210

  Dunleavy, Mark ^a,b   Provenzano, Giovanni ^b   Henshall, David C ^a   Bozzi, Yuri ^b,c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY OF TRENTO   (Italy)

^c CNR   (Italy)

Author keywords

Apoptosis; Dopamine; Epilepsy; Wnt signalling

Indexed keywords

BETA CATENIN; DOPAMINE 2 RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; KAINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; EXCITOTOXICITY; FOCAL EPILEPSY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; KNOCKOUT MOUSE; MOUSE; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SEIZURE; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; BETA CATENIN; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; GLYCOGEN SYNTHASE KINASE 3; KAINIC ACID; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, DOPAMINE D2; SEIZURES; SERINE; TRANSCRIPTION, GENETIC; WNT SIGNALING PATHWAY;

ANIMALIA; MUS;

EID: 84871990584     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9927-x     Document Type: Article

References (34)

1. Baik JH, Picetti R, Saiardi A et al (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377:424-428
2. Beaulieu JM, Del'guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR (2011) Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors. Front Mol Neurosci 4:38
3. Beaulieu JM, Gainetdinov RR, Caron MG (2007a) The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28:166-172
4. Beaulieu JM, Tirotta E, Sotnikova TD et al (2007b) Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 27:881-885
5. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261-273
6. Beaulieu JM, Sotnikova TD, Yao WD et al (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 101:5099-5104
7. Bozzi Y, Borrelli E (2006) Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it? Trends Neurosci 29:167-174
8. Bozzi Y, Dunleavy M, Henshall DC (2011) Cell signaling underlying epileptic behavior. Front Behav Neurosci 5:45
9. Bozzi Y, Vallone D, Borrelli E (2000) Neuroprotective role of dopamine against hippocampal cell death. J Neurosci 20:8643-8649
10. Busceti CL, Biagioni F, Aronica E et al (2007) Induction of the Wnt inhibitor, Dickkopf-1, is associated with neurodegeneration related to temporal lobe epilepsy. Epilepsia 48:694-705
11. Callier S, Snapyan M, Le Crom S, Prou D, Vincent JD, Vernier P (2003) Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell 95:489-502
12. Cotrufo T, Viegi A, Berardi N, Bozzi Y, Mascia L, Maffei L (2003) Effects of neurotrophins on synaptic protein expression in the visual cortex of dark-reared rats. J Neurosci 23:3566-3571
13. Crespo-Biel N, Canudas AM, Camins A, Pallas M (2007) Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus. Neurochem Int 50:435-442
14. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789
15. De Ferrari GV, Inestrosa NC (2000) Wnt signaling function in Alzheimer's disease. Brain Res Rev 33:1-12
16. Gomez-Sintes R, Hernandez F, Lucas JJ, Avila J (2011) GSK-3 mouse models to study neuronal apoptosis and neurodegeneration. Front Mol Neurosci 4:16
17. Hartigan JA, Johnson GV (1999) Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway. J Biol Chem 274:21395-21401
18. Herlaar E, Brown Z (1999) p38 MAPK signalling cascades in inflammatory disease. Mol Med Today 5:439-447
19. Inestrosa NC, Arenas E (2010) Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 11:77-86
20. Iwakura Y, Nawa H, Sora I, Chao MV (2008) Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons. J Biol Chem 283:15799-15806
21. Kawano T, Fukunaga K, Takeuchi Y et al (2001) Neuroprotective effect of sodium orthovanadate on delayed neuronal death after transient forebrain ischemia in gerbil hippocampus. J Cereb Blood Flow Metab 21:1268-1280
22. Kim SW, Yu YM, Piao CS, Kim JB, Lee JK (2004) Inhibition of delayed induction of p38 mitogen-activated protein kinase attenuates kainic acid-induced neuronal loss in the hippocampus. Brain Res 1007:188-191
23. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear [beta]-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3[beta] conditional transgenic mice. EMBO J 20:27-39
24. Noshita N, Lewen A, Sugawara T, Chan PH (2001) Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21:1442-1450
25. Noshita N, Lewén A, Sugawara T, Chan PH (2002) Akt phosphorylation and neuronal survival after traumatic brain injury in mice. Neurobiol Dis 9:294-304
26. Park HJ, Kim HJ, Ra J, Zheng LT, Yim SV, Chung JH (2008) Protective effect of topiramate on kainic acid-induced cell death in mice hippocampus. Epilepsia 49:163-167
27. Rawal N, Corti O, Sacchetti P et al (2009) Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling. Biochem Biophys Res Comm 388:473-478
28. Rojo AI, Rada P, Egea J, Rosa AO, Lopez MG, Cuadrado A (2008) Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death. Mol Cell Neurosci 39:125-132
29. Schauwecker PE, Steward O (1997) Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci U S A 94:4103-4108
30. Starr MS (1996) The role of dopamine in epilepsy. Synapse 22:159-194
31. Sutton LP, Rushlow WJ (2011) The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3. Int J Neuropsychopharmacol 22:1-15
32. Thornton TM, Pedraza-Alva G, Deng BD et al (2008) Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 320:667-670
33. Tripathi PP, Santorufo G, Brilli E, Borrelli E, Bozzi Y (2010) Kainic acid-induced seizures activate GSK-3beta in the hippocampus of D2R-/- mice. Neuroreport 21:846-850
34. Yano S, Morioka M, Fukunaga K et al (2001) Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab 21:351-360